| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| 03/31/2018 |
Director
Trans History: 35
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 355 | $41.70 | 1,683 |
| 03/31/2018 |
Director
Trans History: 49
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 374 | $41.70 | 9,701 |
| 03/31/2018 |
Director
Trans History: 88
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 355 | $41.70 | 26,135 |
| 03/31/2018 |
Director
Trans History: 178
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 355 | $41.70 | 37,917 |
| 03/31/2018 |
Director
Trans History: 29
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 355 | $41.70 | 33,950 |
| 03/31/2018 |
Director
Trans History: 127
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 543 | $41.70 | 51,715 |
| 03/31/2018 |
Director
Trans History: 207
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 374 | $41.70 | 36,106 |
| 03/31/2018 |
Director
Trans History: 145
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 402 | $41.70 | 50,143 |
| 03/31/2018 |
Director
Trans History: 97
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 412 | $41.70 | 26,150 |
| 03/29/2018 |
Chief Risk Officer
Trans History: 120
|
Chief Risk Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8 | $36.36 | 15,023 |
- * Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.